ACADIA Pharmaceuticals Inc. (ACAD) Reaches $27.29 After 3.00% Down Move, Full House Resorts (FLL) Shorts Lowered By 22.22%

May 24, 2017 - By Peter Erickson

Full House Resorts Incorporated (NASDAQ:FLL) had a decrease of 22.22% in short interest. FLL’s SI was 8,400 shares in May as released by FINRA. Its down 22.22% from 10,800 shares previously. With 16,000 avg volume, 1 days are for Full House Resorts Incorporated (NASDAQ:FLL)’s short sellers to cover FLL’s short positions. The SI to Full House Resorts Incorporated’s float is 0.05%. It is 0.00% or $0 reaching $2.35 per share. It is down 40.12% since May 24, 2016 and is uptrending. It has outperformed by 23.42% the S&P500.

The stock of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) is a huge mover today! About 193,333 shares traded. ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) has declined 15.19% since May 24, 2016 and is downtrending. It has underperformed by 31.89% the S&P500.The move comes after 5 months negative chart setup for the $3.28B company. It was reported on May, 24 by Barchart.com. We have $26.47 PT which if reached, will make NASDAQ:ACAD worth $98.40M less.

ACADIA Pharmaceuticals Inc. is a biopharmaceutical company. The company has market cap of $3.28 billion. The Firm is focused on the development and commercialization of medicines for central nervous system disorders. It currently has negative earnings. The Company’s lead drug candidate, NUPLAZID (pimavanserin), is used for the treatment of hallucinations and delusions associated with Parkinson’s disease psychosis (PD Psychosis).

Among 8 analysts covering ACADIA Pharmaceuticals (NASDAQ:ACAD), 5 have Buy rating, 0 Sell and 3 Hold. Therefore 63% are positive. ACADIA Pharmaceuticals had 17 analyst reports since August 7, 2015 according to SRatingsIntel. The firm earned “Outperform” rating on Sunday, August 9 by Cowen & Co. Needham maintained the shares of ACAD in report on Friday, August 7 with “Buy” rating. Leerink Swann initiated the stock with “Mkt Perform” rating in Tuesday, October 4 report. The rating was downgraded by Piper Jaffray to “Overweight” on Friday, August 7. The stock has “Neutral” rating by Piper Jaffray on Thursday, August 27. On Tuesday, May 3 the stock rating was downgraded by Leerink Swann to “Market Perform”. Piper Jaffray upgraded the shares of ACAD in report on Friday, January 22 to “Overweight” rating. Goldman Sachs initiated the shares of ACAD in report on Friday, November 11 with “Neutral” rating. The stock has “Buy” rating by JP Morgan on Friday, September 4. Piper Jaffray downgraded the shares of ACAD in report on Friday, August 7 to “Neutral” rating.

Since December 19, 2016, it had 0 buys, and 6 sales for $9.31 million activity. 157,540 shares were sold by Moore Terrence O, worth $6.27M. Baity Glenn also sold $300,001 worth of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) on Monday, December 19.

Investors sentiment decreased to 1.06 in Q4 2016. Its down 0.14, from 1.2 in 2016Q3. It dived, as 42 investors sold ACADIA Pharmaceuticals Inc. shares while 58 reduced holdings. 31 funds opened positions while 75 raised stakes. 119.51 million shares or 2.68% more from 116.39 million shares in 2016Q3 were reported. D E Shaw And Company Inc holds 0% of its portfolio in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) for 51,446 shares. The New York-based Gilder Gagnon Howe & has invested 0% in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD). The Massachusetts-based State Street has invested 0.01% in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD). Platinum Investment holds 0.03% of its portfolio in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) for 38,300 shares. Advsr Asset Mngmt has invested 0.01% in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD). Next Fincl owns 200 shares or 0% of their US portfolio. Kistler owns 149 shares for 0% of their portfolio. Franklin stated it has 4.22M shares or 0.06% of all its holdings. Earnest Prtnrs Limited Liability Company reported 4,431 shares. Tiaa Cref Investment Mngmt Ltd Com holds 294,533 shares or 0.01% of its portfolio. Hollencrest Secs Ltd Limited Liability Company holds 9,585 shares. Bank & Trust Of America Corp De holds 0% or 392,829 shares in its portfolio. Fincl Architects holds 1,050 shares or 0.01% of its portfolio. Mark Sheptoff Planning Lc has invested 0.01% in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD). Axa holds 0.02% or 169,575 shares.

Since December 6, 2016, it had 4 insider buys, and 0 sales for $21,951 activity. 4,615 Full House Resorts, Inc. (NASDAQ:FLL) shares with value of $9,045 were bought by LANDAU ELLIS.

Full House Resorts, Inc. owns, operates, develops, manages, and/or invests in casinos and related hospitality and entertainment facilities. The company has market cap of $54.43 million. The Company’s casino/resort divisions include the Silver Slipper Casino & Hotel in Hancock County, Mississippi; the Rising Star Casino Resort in Rising Sun, Indiana, and the Northern Nevada segment, which consists of the Grand Lodge Casino in Incline Village, Nevada and Stockman’s Casino in Fallon, Nevada. It currently has negative earnings. The Company’s Development/Management segment includes costs associated with casino-related development and management projects.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: